Toxoplasma gondii is a cosmopolitan protozoan parasite of felids that also has significant implications for the health of wildlife, livestock and humans worldwide. In Australia, feral, stray and domestic cats (Felis catus) are the most important definitive host of T. gondii as they are the only species that can excrete the environmentally resistant oocysts that provide a major source of infection for mammals and birds. In Tasmania, the rapid decline of the Tasmanian devil (Sarcophilus harrisii) may allow an increase in feral cat abundance, thereby increasing the risk of T. gondii infection to a range of susceptible wildlife species. At present, there is scant information on the prevalence of T. gondii infection in feral cat populations across Tasmania. We tested feral cats from 13 regions across Tasmania for the presence of T. gondii–specific IgG antibodies using a modified agglutination test. Results were combined with serosurveys from three previous studies to enable a comparison of seroprevalence among 14 regions across Tasmania. We found that 84.2% (224 of 266) of cats tested positive for T. gondii IgG antibodies. This is among the highest rates of prevalence recorded from Australia, and significantly higher than for most other countries. Adult cats had higher seroprevalence than kittens but there was no difference between sexes. In Tasmania, seroprevalence was high in 12 of 14 regions (range: 79.3–100.0%), with only two regions (Tasman Island and Southern Tasmania) recording significantly lower seroprevalence (≤50%). This suggests a high risk of infection across Tasmania, and has significant implications for wildlife conservation should feral cat abundance increase with the ongoing declines in Tasmanian devils.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 62 • No. 4